Analysts Set Cara Therapeutics, Inc. (NASDAQ:CARA) Target Price at $27.84
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) has been given an average recommendation of “Hold” by the five ratings firms that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating. The average twelve-month price objective among brokers that have issued a report on the stock in […]
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) has been given an average recommendation of “Hold” by the five ratings firms that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating. The average twelve-month price objective among brokers that have issued a report on the stock in […]
